Zhejiang Starry Pharmaceutical Co.,Ltd.’s Net Profit Dropped 86.7% in First Three Quarters of 2022

Zhejiang Starry Pharmaceutical Co.,Ltd. (浙江司太立制药股份有限公司) (603520.SH) reported a net profit of 29.2 million yuan in the first three quarters of 2022, down 86.7% year-on-year.

Meanwhile, the company posted 1.4 billion yuan in revenue, up 5.1% year-on-year.

At the end of the reporting period, it had 5.3 billion yuan in total assets and 3.5 billion yuan in total liabilities, with a liability-to-asset ratio of 65%.